Today: 16 June 2026

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Thanksgiving Travel Warning: FAA Orders 10% Flight Cuts as U.S. Shutdown Hits Day 37; Allegiant Air Sees Risks If Stalemate Reaches Holiday

Thanksgiving Travel Warning: FAA Orders 10% Flight Cuts as U.S. Shutdown Hits Day 37; Allegiant Air Sees Risks If Stalemate Reaches Holiday

The FAA will cut scheduled flights by 10% at 40 major U.S. airports starting Friday, citing safety concerns during the 37-day federal shutdown. Reductions begin at 4% and ramp up to 10% next week, with international flights initially exempt. Allegiant Air reports no booking impact yet but warns a prolonged shutdown could disrupt Thanksgiving travel. No end to the shutdown is in sight.
6 November 2025
·
Cathie Wood Loads Up on Pinterest After 20% Plunge; ARK Adds CRISPR, Trims Roku, Robinhood & Teradyne (Nov 6, 2025)

Cathie Wood Loads Up on Pinterest After 20% Plunge; ARK Adds CRISPR, Trims Roku, Robinhood & Teradyne (Nov 6, 2025)

ARK Invest bought 521,867 Pinterest shares across three funds after the stock fell over 20% on weak holiday-quarter guidance. The firm also added CRISPR Therapeutics and Beam Therapeutics shares earlier in the week. ARK sold 105,576 Roku shares and 56,095 Robinhood shares, and reduced its position in Teradyne. Pinterest projected Q4 revenue below consensus, citing softer ad spending and tougher competition.
6 November 2025
········
Schwab to Acquire Forge Global in $660 Million All‑Cash Deal, Accelerating the Race to Retail Access for Private Shares (Nov. 6, 2025)

Schwab to Acquire Forge Global in $660 Million All‑Cash Deal, Accelerating the Race to Retail Access for Private Shares (Nov. 6, 2025)

Charles Schwab will acquire Forge Global for $660 million in cash, or $45 per share, a 72% premium to Forge’s last close. Both boards approved the deal, with closing expected in the first half of 2026 pending regulatory and shareholder approvals. Forge’s top shareholders, Motive Capital and Deutsche Börse, have agreed to support the transaction. Forge shares surged in premarket trading after the announcement.
6 November 2025
···
Ripple Says ‘No IPO’ — $40B Valuation, $500M Round, and Mastercard RLUSD Pilot Define Its 2026 Game Plan (Nov. 6, 2025)

Ripple Says ‘No IPO’ — $40B Valuation, $500M Round, and Mastercard RLUSD Pilot Define Its 2026 Game Plan (Nov. 6, 2025)

Ripple will not pursue an IPO in the near term, President Monica Long said at the Swell conference in New York on Nov. 5. The company closed a $500 million investment round led by Fortress Investment Group and Citadel Securities, valuing Ripple at $40 billion. Ripple is piloting RLUSD stablecoin settlements for card payments with Mastercard, WebBank, and Gemini.
6 November 2025
···
Solid Power (SLDP) Charges Ahead: Will Solid-State Batteries Supercharge Its Stock?

Solid Power (SLDP) Charges Ahead: Will Solid-State Batteries Supercharge Its Stock?

Solid Power, Inc., based in Colorado, develops all-solid-state batteries for electric vehicles using a proprietary sulfide-based solid electrolyte. The company, which went public via SPAC in late 2021 and trades as SLDP, licenses its technology and sells materials rather than manufacturing batteries. Ford, BMW, and SK Innovation are key partners. SLDP stock has risen over 400% in the past year, reaching a $1.3 billion market cap.
5 November 2025
··
Perrigo (PRGO) Stock Plunges to 52-Week Low as Outlook Slashed – What Investors Need to Know

Perrigo (PRGO) Stock Plunges to 52-Week Low as Outlook Slashed – What Investors Need to Know

Perrigo shares traded near a 52-week low at $20.20 on Nov. 5, 2025, after the company cut its 2025 earnings outlook and reported a 4.1% year-over-year drop in Q3 revenue to $1.04 billion. Market cap stands at $2.8 billion. The company now expects adjusted EPS of $2.70–$2.80 for the year on a net sales decline of up to 3%. Quarterly dividend remains $0.29 per share, yielding about 5.7%.
5 November 2025
·
Teradata’s 19% Stock Surge: AI Ambitions, Earnings Beat & What’s Next for TDC Investors

Teradata’s 19% Stock Surge: AI Ambitions, Earnings Beat & What’s Next for TDC Investors

Teradata shares surged 19% to $24.64 on November 5 after Q3 earnings beat estimates, with adjusted EPS at $0.72 versus $0.53 expected and revenue of $416 million. The stock broke above its 200-day moving average. Cloud ARR rose 11% year-over-year. Management reaffirmed 2025 guidance and reported $88 million in Q3 free cash flow.
5 November 2025
···
Supreme Court Tariff Showdown: Trump’s Trillion-Dollar Trade Gamble Meets Skeptical Justices

Supreme Court Tariff Showdown: Trump’s Trillion-Dollar Trade Gamble Meets Skeptical Justices

The U.S. Supreme Court on Nov. 5, 2025, heard arguments challenging President Donald Trump’s global tariffs imposed under a 1977 emergency law. Justices from both wings questioned whether Trump usurped Congress’s exclusive power to levy import duties. The tariffs, ranging from 10% to over 100%, have disrupted supply chains and drawn opposition from 12 states and business groups. The administration claims the tariffs are regulatory, not taxes.
5 November 2025
SoFi Stock Soars 171% to Record Highs on Breakout Earnings – Will the Rally Continue? (Nov 2025 Update)

SoFi Stock Soars 171% to Record Highs on Breakout Earnings – Will the Rally Continue? (Nov 2025 Update)

SoFi Technologies stock surged 171% year-over-year, hitting a record $32.57 in late October before settling near $29–30 on November 5. Q3 2025 net revenue reached $962 million, up 38%, with net income of $139 million. Management raised 2025 revenue guidance to $3.5–3.54 billion and EPS to $0.37. Membership climbed to 12.6 million, up 35% from a year ago.
5 November 2025
··
Pfizer Stock Plunge and Promise: Vaccine Slump, Weight-Loss War, and a $10B Gamble – Is PFE Poised for a Comeback?

Pfizer Stock Plunge and Promise: Vaccine Slump, Weight-Loss War, and a $10B Gamble – Is PFE Poised for a Comeback?

Pfizer closed at $24.45 on Nov. 5, 2025, with a market cap near $138 billion, more than 60% below its pandemic-era peak. Q3 revenue fell 6% to about $16.7 billion, while adjusted earnings beat forecasts at $0.87 per share. COVID-19 product sales continued to drop sharply. Pfizer is in a bidding war with Novo Nordisk for obesity drug developer Metsera.
5 November 2025
··
Cipher Mining Stock Skyrockets on Blockbuster AWS Deal – Latest Earnings, Expert Insights & Price Forecast

Cipher Mining Stock Skyrockets on Blockbuster AWS Deal – Latest Earnings, Expert Insights & Price Forecast

Cipher Mining shares surged over 22% in a day and climbed 30% in a week after announcing a $5.5 billion, 15-year AWS data center deal and posting a surprise Q3 profit. The company reported $72 million in Q3 revenue and $0.10 adjusted EPS, beating expectations. Cipher also launched a West Texas data center project and completed a $1.3 billion convertible note offering. Analyst price targets rose to as high as $33.
5 November 2025
··
Rubico (RUBI) Stock in Freefall: Top Ships Spin-Off Collapses 90% – What Investors Should Know

Rubico (RUBI) Stock in Freefall: Top Ships Spin-Off Collapses 90% – What Investors Should Know

Rubico Inc. shares plunged 55% to $0.29 on Nov. 5, 2025, after announcing a $7.5 million dilutive offering, leaving its market cap below $2 million. The Greek tanker spin-off operates two Suezmax crude oil vessels on long-term charters but faces high debt and low liquidity. Retail traders remain bullish despite a 90% drop from its August debut. No institutional ownership or analyst coverage reported.
5 November 2025
·
First Majestic Silver (AG) Shines on Silver’s Surge – But Can the Rally Sustain?

First Majestic Silver (AG) Shines on Silver’s Surge – But Can the Rally Sustain?

First Majestic Silver shares fell 8.5% to $10.57 on November 5 after Q3 earnings missed estimates, despite record revenue of $285.1 million and net income of $43 million. Trading volume surged to 12.8 million shares. The Los Gatos mine contributed 45% of revenue, while all-in sustaining costs dropped to $20.90/oz. The company ended Q3 with $568.8 million in treasury and declared a $0.0052 dividend.
5 November 2025
·
Rigel Pharmaceuticals (RIGL) Stock Skyrockets on Earnings Beat – Latest Drug Updates & Analyst Outlook

Rigel Pharmaceuticals (RIGL) Stock Skyrockets on Earnings Beat – Latest Drug Updates & Analyst Outlook

Rigel Pharmaceuticals shares jumped over 30% to around $38 on Nov. 5, 2025, after reporting Q3 revenue of $69.5 million, up 25% year-over-year. Net income reached $27.9 million, and the company raised its 2025 revenue guidance to $285–$290 million. Product sales, led by Tavalisse, surged 65%. Rigel also announced new clinical milestones and ongoing global partnerships.
5 November 2025
··
Lumentum Stock Skyrockets on AI Boom – Record Sales & Bold Forecast

Lumentum Stock Skyrockets on AI Boom – Record Sales & Bold Forecast

Lumentum reported record fiscal Q1 2026 revenue of $533.8 million, up 58% year-over-year, and returned to profit with $4.2 million net income after a loss last year. Shares surged as much as 20% to a 52-week high near $227 following bullish Q2 guidance and strong AI-driven demand. Over 60% of revenue now comes from cloud and AI infrastructure. Wall Street raised price targets, citing accelerating growth.
5 November 2025
··
Kratos Defense (KTOS) Soars 300% on Drone Boom – Is the Rally Sustainable?

Kratos Defense (KTOS) Soars 300% on Drone Boom – Is the Rally Sustainable?

Kratos Defense shares fell to the mid-$70s after Q3 revenue beat estimates but Q4 guidance missed forecasts, cutting market cap to $13 billion. The company announced a $356.3 million cash acquisition of Israel’s Orbit Technologies and raised 2025 revenue guidance. Year-to-date, the stock is up over 300%, hitting a 21-year high in October. Analyst consensus is “Moderate Buy” with targets ranging from $77 to $125.
5 November 2025
···
Babcock & Wilcox (BW) Stock Skyrockets on AI Power Deal – Key Facts, Q3 Earnings & 2025 Outlook

Babcock & Wilcox (BW) Stock Skyrockets on AI Power Deal – Key Facts, Q3 Earnings & 2025 Outlook

Babcock & Wilcox shares jumped nearly 40% to $5.19 on Nov. 5 after announcing a $1.5 billion AI data center power project with Applied Digital. The company posted a smaller Q3 net loss of $2.3 million and sold its A-S-H business for $29 million, using proceeds to redeem $26 million in debt. BW also launched a $200 million at-the-market stock sale. Analysts upgraded the stock but flagged ongoing liquidity risks.
5 November 2025
·····
Trex Stock Plunges on Earnings Miss – What’s Next for the Decking Leader?

Trex Stock Plunges on Earnings Miss – What’s Next for the Decking Leader?

Trex Company shares plunged about 25% in early November 2025 after missing Q3 earnings estimates and cutting full-year guidance, hitting multi-year lows in the mid-$30s. Analysts downgraded the stock and slashed price targets following the report. Q3 revenue reached $285 million, up 22% year-over-year, but management cited weak demand and margin pressure. Trading volume spiked as the stock broke below key support levels.
5 November 2025
···
From Crash to Breakthrough: Why Lunai Bioworks (LNAI) Is Suddenly on Investors’ Radar

From Crash to Breakthrough: Why Lunai Bioworks (LNAI) Is Suddenly on Investors’ Radar

Lunai Bioworks (NASDAQ: LNAI) shares surged over 15% to around $1 after announcing preclinical success in pancreatic cancer immunotherapy on Nov. 5, 2025. The stock remains down more than 85% year-over-year and trades near all-time lows after a 10:1 reverse split in September. Lunai is pre-revenue, posted a $178 million net loss over the past year, and faces severe liquidity issues.
5 November 2025
···
Biohaven (BHVN) Stock Plunges on FDA Setback – Will Its Biotech Pipeline Fuel a Comeback?

Biohaven (BHVN) Stock Plunges on FDA Setback – Will Its Biotech Pipeline Fuel a Comeback?

Biohaven Ltd. shares plunged about 40% on Nov. 5, 2025, after the FDA rejected its lead drug VYGLXIA for spinocerebellar ataxia, citing trial design and data issues. The company will cut R&D spending by 60% and halt non-priority programs. Analysts downgraded the stock, which now trades near $8–9, down over 70% year-over-year. Biohaven reported a $198 million net loss in Q2 with $408 million in cash.
5 November 2025
·
1 … 50 51 52 53 54 … 148

Stock Market Today

  • FTSE 100's Barratt Redrow Down 33%, Offers 5.6% Dividend Yield Amid Market Uncertainty
    June 16, 2026, 3:06 PM EDT. Barratt Redrow, a major UK housebuilder, has seen its shares drop 33% in 2026 but offers a compelling 5.6% dividend yield. Despite economic challenges including inflationary pressures tied to the Iran conflict, the company remains on track with strong forward sales of £3.54 billion and aims to complete up to 17,800 homes this year. CEO David Thomas signals resilience with raised net cash guidance between £550 million and £650 million. RBC Capital rates Barratt and Persimmon as market leaders, assigning a 350p price target-up 38% from current levels-due to a modest 10 P/E ratio forecast for 2026. While housing demand remains supported by chronic shortages, valuation concerns linked to broader market fears persist. Investors face uncertainty over the sector's recovery timing amid dividend yield cuts and ongoing market volatility.

Latest articles

Ford Shares Dip After China Software Rule Adds Fresh Risk

Ford Shares Dip After China Software Rule Adds Fresh Risk

16 June 2026
Ford shares slipped 1.1% to $14.61 after Reuters reported the company needs U.S. approval to keep importing China-built Lincoln Nautilus SUVs due to new connected-vehicle rules, raising fresh regulatory uncertainty for investors ahead of Ford’s expected Q2 earnings report.
MARA Holdings Jumps After Bitcoin Treasury Update Brings Miner Into View

MARA Holdings Jumps After Bitcoin Treasury Update Brings Miner Into View

16 June 2026
MARA Holdings surged 2.1% to $14.94 on heavy volume, outperforming the Nasdaq, as investors focused on speculation about a 1,000-Bitcoin treasury purchase reported by Crypto.news, though MARA has not confirmed the transaction; the stock’s rally comes despite Q1 revenue and net loss declines, with analysts holding a mixed view and price targets averaging $17–$18.38, reflecting high volatility and ongoing execution risks.
Go toTop